America Great Health
AAGH · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.00 | 1.02 | 0.00 |
| FCF Yield | -0.42% | 4.20% | -0.16% | -4.65% |
| EV / EBITDA | -187.78 | -39.83 | -918.11 | -21.08 |
| Quality | ||||
| ROIC | 2.99% | 4.30% | 2.63% | 15.89% |
| Gross Margin | 88.72% | 91.38% | 91.91% | -9.04% |
| Cash Conversion Ratio | 0.34 | -0.46 | 0.65 | 0.50 |
| Growth | ||||
| Revenue 3-Year CAGR | 71.54% | 120.71% | 39.05% | 41.21% |
| Free Cash Flow Growth | -160.26% | 192.88% | 67.54% | -383.36% |
| Safety | ||||
| Net Debt / EBITDA | -32.30 | -21.73 | -36.66 | -5.84 |
| Interest Coverage | -1.17 | -1.65 | -0.93 | -2.44 |
| Efficiency | ||||
| Inventory Turnover | 0.06 | 0.07 | 0.10 | 1.25 |
| Cash Conversion Cycle | -18,880.83 | -15,201.74 | -10,592.01 | -1,115.44 |